Functional assays indicate that IFNγ contributes to CTL-mediated tumor cell death by acting in concert with granzyme B and perforin to increase cytotoxicity and promote apoptosis via the IFNγ-STAT1-caspase-3 pathway. The gene discussed is PRF1; the disease is neoplasm.